title: Answer to the "comment on functional consequences of Kv1.3 ion channel rearrangement into the immunological synapse" by Stefan Bittner et al. [Immunol. Lett. 125 (Aug 15 (2)) (2009) 156-157].
authors.forename: Péter
authors.initials: P
authors.lastname: Hajdú
authors.forename: Orsolya
authors.initials: O
authors.lastname: Szilágyi
authors.forename: Agnes
authors.initials: A
authors.lastname: Tóth
authors.forename: Zoltán
authors.initials: Z
authors.lastname: Krasznai
authors.forename: Krisztina
authors.initials: K
authors.lastname: Pocsai
authors.forename: György
authors.initials: G
authors.lastname: Panyi
mesh_terms: D000818:Animals; D055724:Electrophysiological Phenomena; D054992:Immunological Synapses / Q000378:metabolism*; D051664:Kv1.3 Potassium Channel / Q000276:immunology / Q000378:metabolism*; D008213:Lymphocyte Activation / Q000187:drug effects; D051379:Mice; D026902:Potassium Channel Blockers / Q000494:pharmacology; D024683:Potassium Channels, Tandem Pore Domain / Q000276:immunology / Q000378:metabolism*; D012604:Scorpion Venoms / Q000494:pharmacology; D018418:Th2 Cells / Q000187:drug effects / Q000276:immunology / Q000378:metabolism* / Q000473:pathology
chemical_list: D051664:Kv1.3 Potassium Channel; D026902:Potassium Channel Blockers; D024683:Potassium Channels, Tandem Pore Domain; D012604:Scorpion Venoms; C077910:margatoxin